In particular, if it can be verified through animal models or organoid models whether Rab22a really has the effect of promoting tumor cell invasion, metastasis, and enhancing EMT for papillary thyroid carcinoma and other histological subtypes in vivo, it will be more convincing and may also reveal more complex related mechanisms. This evidence concerns the gene RAB22A and differentiated thyroid carcinoma.